AU Patent

AU2004281535A1 — Connector for medical liquid-containing packages and medical liquid-containing packages

Assigned to Fresenius Kabi Deutschland GmbH · Expires 2005-04-28 · 21y expired

What this patent protects

Patent listed against ropivacaine-hydrochloride.

Drugs covered by this patent

ropivacaine-hydrochloride (ROPIVACAINE HYDROCHLORIDE)

Patent Metadata

Patent number: AU2004281535A1
Jurisdiction: AU
Classification: —
Expires: 2005-04-28
Drug substance claim: No
Drug product claim: No
Assignee: Fresenius Kabi Deutschland GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.